Jim Simons Novo Cure LTD Transaction History

Renaissance Technologies LLC

$63.4 Billion
Q4 2024

A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Novo Cure LTD stock. As of the latest transaction made, Renaissance Technologies LLC holds 734,354 shares of NVCR stock, worth $16.2 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

734,354

Previous 744,154 1.32%

Holding current value

$16.2 Million

Previous $11.6 Million 88.14%

% of portfolio

0.03%

Previous 0.02%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	SELL	$14.54 - $33.41 $142,492 - $327,417	-9,800 Reduced 1.32%	734,354 $21.9 Million
Q3 2024 Nov 13, 2024	SELL	$15.61 - $23.34 $250,087 - $373,930	-16,021 Reduced 2.11%	744,154 $11.6 Million
Q2 2024 Aug 09, 2024	BUY	$11.83 - $24.05 $5.69 Million - $11.6 Million	480,600 Added 171.9%	760,175 $13 Million
Q1 2024 May 13, 2024	BUY	$12.42 - $17.29 $2.21 Million - $3.08 Million	178,200 Added 175.78%	279,575 $4.37 Million
Q4 2023 Feb 13, 2024	BUY	$11.13 - $15.78 $1.13 Million - $1.6 Million	101,375 New	101,375 $1.51 Million
Q2 2022 Aug 12, 2022	SELL	$56.6 - $89.9 $1.67 Million - $2.66 Million	-29,589 Reduced 61.68%	18,386 $1.28 Million
Q1 2022 May 13, 2022	SELL	$60.15 - $84.52 $7.89 Million - $11.1 Million	-131,116 Reduced 73.21%	47,975 $3.98 Million
Q4 2021 Feb 11, 2022	SELL	$75.08 - $121.99 $2.62 Million - $4.26 Million	-34,884 Reduced 16.3%	179,091 $13.4 Million
Q3 2021 Nov 12, 2021	SELL	$116.17 - $194.55 $1.49 Million - $2.49 Million	-12,800 Reduced 5.64%	213,975 $24.9 Million
Q2 2021 Aug 13, 2021	SELL	$130.4 - $225.58 $23.7 Million - $41 Million	-181,800 Reduced 44.5%	226,775 $50.3 Million
Q1 2021 May 13, 2021	BUY	$124.11 - $190.17 $13.7 Million - $21 Million	110,605 Added 37.12%	408,575 $54 Million
Q4 2020 Feb 10, 2021	SELL	$112.16 - $174.14 $76.2 Million - $118 Million	-679,700 Reduced 69.52%	297,970 $51.6 Million
Q3 2020 Nov 13, 2020	SELL	$58.05 - $111.31 $59.4 Million - $114 Million	-1,022,900 Reduced 51.13%	977,670 $109 Million
Q2 2020 Aug 13, 2020	SELL	$57.2 - $74.41 $14 Million - $18.2 Million	-244,900 Reduced 10.91%	2,000,570 $119 Million
Q1 2020 May 14, 2020	BUY	$57.05 - $95.75 $198,248 - $332,731	3,475 Added 0.15%	2,245,470 $151 Million
Q4 2019 Feb 13, 2020	SELL	$68.3 - $93.8 $9.14 Million - $12.5 Million	-133,775 Reduced 5.63%	2,241,995 $189 Million
Q3 2019 Nov 13, 2019	BUY	$61.86 - $97.8 $19.8 Million - $31.3 Million	320,300 Added 15.58%	2,375,770 $178 Million
Q2 2019 Aug 12, 2019	BUY	$42.22 - $63.23 $8.41 Million - $12.6 Million	199,200 Added 10.73%	2,055,470 $130 Million
Q1 2019 May 14, 2019	BUY	$31.96 - $56.12 $25.1 Million - $44.1 Million	785,800 Added 73.41%	1,856,270 $89.4 Million
Q4 2018 Feb 13, 2019	BUY	$28.72 - $52.63 $30.7 Million - $56.3 Million	1,070,470 New	1,070,470 $35.8 Million

Others Institutions Holding NVCR

# of Institutions

290

Shares Held

75.6M

Call Options Held

1.77M

Put Options Held

538K

View Full List

About NovoCure Ltd

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $2.32B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

More about NVCR

Track Jim Simons's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Account